BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210517T130000
DTEND;TZID=America/New_York:20210517T170000
DTSTAMP:20210503T155329Z
CREATED:20210317T191440Z
LAST-MODIFIED:20210503T155329Z
UID:13408-1621256400-1621270800@scienceinboston.com
SUMMARY:Symposium: Engineering Cancer Immunotherapy
DESCRIPTION:Cancer Immunotherapy has emerged as a major component of cancer treatment. This symposium aims to catalyze new approaches to anti-cancer immunity in settings where it is currently limited by bringing together bioengineers\, cancer immunologists and oncologists. \nFeatured topics \nMechanisms of Protective Tumor Immunity\nGlenn Dranoff\, M.D.\nNovartis \nSingle-cell sequencing of T cells in food allergy\nJ. Christopher Love\, Ph.D.\nMassachusetts Institute of Technology \nMoving Forward CAR T Cell Therapies for Multiple Myeloma and Beyond\nEric Smith\, M.D.\, Ph.D.\nDana-Farber Cancer Institute \nImmunotherapeutic Drug Delivery to Lymph Nodes Augments Cancer Immunotherapy\nSusan Thomas\, Ph.D.\nGeorgia Tech \nMolecular Understanding of T Cell Exhaustion and Role in Disease\nE. John Wherry\, Ph.D.\nPerelman School of Medicine\, University of Pennsylvania
URL:https://scienceinboston.com/event/symposium-engineering-cancer-immunotherapy/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2021/03/Symposium-Engineering-Cancer-Immunotherapy.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210517T130000
DTEND;TZID=America/New_York:20210517T170000
DTSTAMP:20210317T191440Z
CREATED:20210317T191440Z
LAST-MODIFIED:20210317T191440Z
UID:27674-1621256400-1621270800@scienceinboston.com
SUMMARY:Symposium: Engineering Cancer Immunotherapy
DESCRIPTION:Cancer Immunotherapy has emerged as a major component of cancer treatment. This symposium aims to catalyze new approaches to anti-cancer immunity in settings where it is currently limited by bringing together bioengineers\, cancer immunologists and oncologists. \nFeatured topics \nMechanisms of Protective Tumor Immunity\nGlenn Dranoff\, M.D.\nNovartis \nSingle-cell sequencing of T cells in food allergy\nJ. Christopher Love\, Ph.D.\nMassachusetts Institute of Technology \nMoving Forward CAR T Cell Therapies for Multiple Myeloma and Beyond\nEric Smith\, M.D.\, Ph.D.\nDana-Farber Cancer Institute \nImmunotherapeutic Drug Delivery to Lymph Nodes Augments Cancer Immunotherapy\nSusan Thomas\, Ph.D.\nGeorgia Tech \nMolecular Understanding of T Cell Exhaustion and Role in Disease\nE. John Wherry\, Ph.D.\nPerelman School of Medicine\, University of Pennsylvania
URL:https://scienceinboston.com/event/symposium-engineering-cancer-immunotherapy-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2021/03/Symposium-Engineering-Cancer-Immunotherapy.jpg
END:VEVENT
END:VCALENDAR